Browsing by Author Muñoz Mateu, Montserrat
Showing results 5 to 19 of 19
< previous
Issue Date | Title | Author(s) |
---|---|---|
1-Oct-2021 | Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study | Kahan, Zsuzsanna; Gil Gil, Miguel; Ruiz Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli, Mireia; Antón, Antonio; Casas, Maribel; Csöszi, Tibor; Murillo, Laura; Morales, Serafín; Calvo, Lourdes; Lang, Istvan; Alba, Emilio; Haba Rodriguez, Juan de la; Ramos, Manuel; Álvarez López, Isabel; Gal Yam, Einav; García Palomo, Andrés; Alvarez, Elena; González Santiago, Santiago; Rodríguez, César A.; Servitja, Sonia; Corsaro, Massimo; Rodrigálvarez, Graciela; Zielinski, Christoph; Martín, Miguel |
19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
23-Jan-2014 | Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity. | Almendro Navarro, Vanessa; Cheng, Yu-Kan; Randles, Amanda; Itzkovitz, Shalev; Marusyk, Andriy; Ametller, Elisabet; Gonzalez-Farre, Xavier; Muñoz Mateu, Montserrat; Russnes, Hage G.; Helland, Åslaug; Rye, Inga H.; Borresen-Dale, Anne-Lise; Maruyama, Reo; Oudenaarden, Alexander van; Dowsett, Mitchell; Jones, Robin L.; Reis-Filho, Jorge; Gascón, Pere; Gönen, Mithat; Michor, Franziska; Polyak, Kornelia |
21-Oct-2013 | Infrequent loss of luminal differentiation in ductal breast cancer metastasis | Calvo, Julia; Sánchez-Cid Pérez, Lourdes; Muñoz Mateu, Montserrat; Lozano Salvatella, Juan José; Thomson, Timothy M.; Fernández Ruiz, Pedro Luis |
8-Nov-2022 | Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case Report | Schettini, Francesco; Seguí, Elia; Conte, Benedetta; Sanfeliu, Esther; González Farré, Blanca; Jares Gerboles, Pedro; Vidal i Sicart, Sergi; Ganau, Sergi; Cebrecos, Isaac; Brasó Maristany, Fara; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix; Vidal Losada, Maria Jesús |
28-Mar-2017 | Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer | Fernández Martínez, Aranzazu; Pascual, Tomás; Perrone, Giuseppe; Morales, Serafín; Haba, Juan de la; González Rivera, Milagros; Galván, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucía; Prats de Puig, Miquel; Rojo, Federico; Manso, Luis; Paré, Laia; Alonso, Immaculada; Albanell Mestres, Joan; Vivancos, Ana; González, Antonio; Matito, Judit; González, Sonia; Fernández Ruiz, Pedro Luis; Adamo, Barbara; Muñoz Mateu, Montserrat; Viladot, Margarita; Font, Carme; Aya, Francisco; Vidal Losada, Maria Jesús; Caballero, Rosalía; Carrasco, Eva; Altomare, Vittorio; Tonini, Giuseppe; Prat Aparicio, Aleix; Martín, Miguel |
7-Mar-2019 | Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study | Lope, Virginia; Martín, Miguel; Castelló, Adela; Ruiz, Amparo; Casas, Ana Ma.; Baena Cañada, José Manuel; Antolín, Silvia; Ramos-Vázquez, Manuel; García-Sáenz, José Ángel; Muñoz Mateu, Montserrat; Lluch, Ana; de Juan-Ferré, Ana; Jara, Carlos; Sánchez-Rovira, Pedro; Antón, Antonio; Chacón, José Ignacio; Arcusa, Angels; Jimeno, Mª Angeles; Bezares Susana; Vioque, Jesús; Carrasco, Eva; Pérez-Gómez, Beatriz; Pollán, Marina |
1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
8-May-2020 | Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study | Fernández de Larrea Baz, Nerea; Pérez Gómez, Beatriz; Guerrero Zotano, Angel; Casas, Ana Ma.; Bermejo de las Heras, Begoña; Baena Cañada, José Manuel; Antolin, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; García Sáenz, José Ángel; Antón, Antonio; Muñoz Mateu, Montserrat; Juan, Ana de; Jara, Carlos; Chacón, José Ignacio; Arcusa, Angels; Gil Gil, Miguel; Adrover, Encarna; Oltra, Amparo; Brunet, Joan; González, Sonia; Bezares, Susana; Lope, Virginia; Martín, Miguel; Pollán, Marina |
18-Dec-2015 | Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. | Prat Aparicio, Aleix; Fan, Cheng; Fernández Martínez, Aranzazu; Hoadley, Katherine A.; Martinello, Rossella; Vidal Losada, Maria Jesús; Viladot, Margarita; Pineda, Estela; Arance, Ana; Muñoz Mateu, Montserrat; Paré, Laia; Cheang, Maggie C. U.; Adamo, Barbara; Perou, Charles M. |
9-Jan-2019 | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial | Gavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix |
1-Oct-2020 | Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype | Lope, Virginia; Guerrero Zotano, Ángel; Casas, Ana; Baena Cañada, José Manuel; Bermejo, Begona; Pérez Gómez, Beatriz; Criado Navarro, Inmaculada; Antolín, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; Antón, Antonio; Castelló, Adela; García Saenz, Jose Angel; Muñoz Mateu, Montserrat; Juan, Ana de; Andrés, Raquel; Llombart Cussac, Antonio; Hernando, Blanca; Franquesa, Rosa María; Caballero, Rosalía; Priego Capote, Feliciano; Martón, Miguel; Pollán, Marina |
7-Jun-2019 | Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis | Pascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic Ruché, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |